New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - daunorubicin hydrochloride 2.14 mg/ml equivalent to daunorubicin 2 mg/ml - solution for injection - 2 mg/ml - active: daunorubicin hydrochloride 2.14 mg/ml equivalent to daunorubicin 2 mg/ml excipient: sodium chloride water for injection - daunorubicin injection is indicated for the treatment of the following: · acute lymphocytic (lymphoblastic) leukaemia: daunorubicin is usually reserved for use in cases shown to be resistant to other drugs. however, combined treatment with daunorubicin, vincristine and a steroid has been used in the early stages of this disease.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - mitoxantrone hydrochloride 2.3284 mg/ml equivalent to mitoxantrone 2 mg/ml. australian approved name is mitozantrone hydrochloride. - solution for injection - 2 mg/ml - active: mitoxantrone hydrochloride 2.3284 mg/ml equivalent to mitoxantrone 2 mg/ml. australian approved name is mitozantrone hydrochloride. excipient: glacial acetic acid hydrochloric acid nitrogen sodium acetate sodium chloride sodium sulfate water for injection - mitozantrone ebewe is indicated for the treatment of: · metastatic carcinoma of the breast · non-hodgkin's lymphoma · adult acute non-lymphocytic leukaemia (anll) · chronic myelogenous leukaemia in blast crisis

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - daunorubicin, quantity: 20 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - indications as at 22 november 2004 : daunorubicin injection is indicated for the treatment of the following: acute lymphocytic (lymphoblastic) leukaemia: daunorubicin is usually reserved for use in cases shown to be resistant to other drugs. however, combined treatment with daunorubicin, vincristine and a steroid has been used in the early stages of this disease. acute myeloblastic leukaemia: daunorubicin has been used in all stages, alone or in combination with other cytotoxic agents (e.g. cytarabine). disseminated solid tumours: daunorubicin has been investigated for use in these tumours and found to be effective in some cases of disseminated neuroblastoma and rhabdomyosarcoma.

Irland - engelsk - HPRA (Health Products Regulatory Authority)

claris lifesciences (uk) limited - ondansetron hydrochloride dihydrate - solution for injection - 2 mg/ml - serotonin (5ht3) antagonists

Malta - engelsk - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - ondansetron hydrochloride, dihydrate - solution for injection/infusion - ondansetron hydrochloride dihydrate 2 mg/ml - antiemetics and antinauseants

Malta - engelsk - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - ondansetron hydrochloride, dihydrate - solution for injection/infusion - ondansetron hydrochloride dihydrate 2 mg/ml - antiemetics and antinauseants

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mitozantrone hydrochloride, quantity: 2.328 mg/ml (equivalent: mitozantrone, qty 2 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - for the treament of: *locally advanced or metastatic carcinoma of the breast *non-hodgkin's lymphoma *adult acute non-lymphocytic leukaemia (anll) *chronic myelogenous leukaemia in blast crisis.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mitozantrone hydrochloride, quantity: 2.328 mg/ml (equivalent: mitozantrone, qty 2 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - for the treatment of: *locally advanced or metastatic carcinoma of the breast *non-hodgkin's lymphoma *adult acute non-lymphocytic leukaemia (anll) *chronic myelogenous leukaemia in blast crisis.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mitozantrone hydrochloride, quantity: 2.328 mg/ml (equivalent: mitozantrone, qty 2 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - for the treament of: *locally advanced or metastatic carcinoma of the breast *non-hodgkin's lymphoma *adult actue non-lymphocytic leukaemia (anll) *chronic myelogenous leukaemia in blast crisis.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mitozantrone hydrochloride, quantity: 2.328 mg/ml (equivalent: mitozantrone, qty 2 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - for the treatment of *locally advanced or metastatic carcinoma of the breast *non-hodgkin's lymphoma *adult acute non-lymphocytic leukaemia (anll) *chronic myelogenous leukaemia in blast crisis.